O Giles Best Selected Research

Rituximab (Mabthera)

1/2022

Fludarabine nucleoside induces major changes in the p53 interactome in human B-lymphoid cancer cell lines.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

O Giles Best Research Topics

Disease

13	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2022 - 07/2012
6	Neoplasms (Cancer) 01/2022 - 01/2014
3	Lymphoma (Lymphomas) 01/2022 - 01/2014
3	Cystic Fibrosis (Mucoviscidosis) 01/2009 - 10/2006
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 01/2022 - 01/2014
1	Multiple Myeloma 01/2022
1	Liver Diseases (Liver Disease) 01/2017
1	Leukemia 12/2015
1	Burkitt Lymphoma (Burkitt's Lymphoma) 01/2014
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2013
1	Infections 01/2013
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 06/2012

Drug/Important Bio-Agent (IBA)

7	fludarabineIBA 01/2022 - 06/2012
5	Proteins (Proteins, Gene)FDA Link 01/2022 - 04/2007
3	NucleosidesIBA 01/2022 - 01/2014
3	SNX-7081IBA 12/2015 - 07/2012
2	Membrane Proteins (Integral Membrane Proteins)IBA 01/2017 - 01/2016
2	NucleotidesIBA 01/2009 - 04/2007
2	Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA 04/2007 - 10/2006
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Rituximab (Mabthera)FDA Link 01/2022
1	MK 2206IBA 01/2019
1	binimetinibIBA 01/2019
1	Immobilized AntibodiesIBA 01/2016
1	Pharmaceutical PreparationsIBA 12/2015
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2015
1	purineIBA 01/2014
1	Protein Kinase CIBA 10/2013
1	Protein Isoforms (Isoforms)IBA 10/2013
1	Phosphatidylinositols (Phosphatidylinositol)IBA 06/2013
1	Phosphoric Monoester Hydrolases (Phosphatases)IBA 06/2013
1	TensinsIBA 06/2013
1	Immunoglobulin G (IgG)IBA 01/2013
1	Immunoglobulins (Immunoglobulin)IBA 01/2013
1	5- (2,4- dihydroxy- 5- isopropylphenyl)- 4- (4- morpholin- 4- ylmethylphenyl)isoxazole- 3- carboxylic acid ethylamideIBA 11/2012
1	Casein Kinase II (Casein Kinase 2)IBA 01/2009
1	cystic fibrosis transmembrane conductance regulator delta F508IBA 01/2009
1	Phenylalanine (L-Phenylalanine)FDA Link 04/2007

Therapy/Procedure

3	Therapeutics 02/2015 - 10/2013
1	Aftercare (After-Treatment) 01/2014